Business Wire

First Patients in Europe Treated Following CE Approval for GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis

Jaa

W. L. Gore & Associates, Inc. (Gore) has announced that the first implants occurred in Europe to restore blood flow to peripheral arteries using the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft). The new device is designed for use in the treatment of iliac occlusive disease and also during endovascular aneurysmal repair. The first patients were treated at St. Franziskus Hospital in Münster, Germany.

“We are continuing to elevate and enhance our cardiovascular care offerings with this new technology that more reliably treats peripheral arteries in a minimally invasive way,” said Giovanni Torsello, MD, Professor and Chief of the Department of Vascular Surgery, St. Franziskus Hospital. “The VBX Stent Graft demonstrates a notable, unique combination of technical features beneficial in a broad range of vessels with complex anatomy. Flexibility and accuracy are clearly noticeable. In addition, the VBX Stent Graft provides precise delivery that we can rely on.”

PROCEDURAL SUMMARY

The physicians at St. Franziskus Hospital are among a select group of leaders in their field who have been first in Europe to provide the VBX Stent Graft to patients. The VBX Stent Graft recently received CE mark approval and is indicated for endovascular grafting of peripheral vessels.

The patients who received the VBX Stent Grafts presented with iliac occlusive disease and also complex aortic aneurysms treated with branched aortic endograft (BEVAR).

AVAILABILITY

The VBX Stent Graft was developed utilizing the small diameter, ePTFE stent graft technology from the GORE® VIABAHN® Endoprosthesis. The VBX Stent Graft is configured in a range of diameters from 5 to 11 millimeters and lengths of 15, 19, 29, 39, 59, and 79 millimeters to cover a wide variety of treatment needs. The VBX Stent Graft does not require pre-dilation, which reduces the number of balloons required, and the longer lengths reduce the need to use multiple stents for extensive lesions, both of which also contribute to procedural cost savings.

“The VBX Stent Graft combines an implant with radial strength and conformability to the anatomy along with a trackable delivery system that results in successful outcomes for patients, providers, and physicians,” said Eric Zacharias, Vascular Business Leader. “We look forward to introducing the VBX Stent Graft throughout Europe during 2018.”

Gore provides a portfolio of peripheral vascular solutions that are designed and tested for physicians to more reliably treat patients with a wide range of challenging peripheral disease presentations and improve those patients’ outcomes.* Each interventional solution is engineered for durability, accuracy, thromboresistance, and conformability, and is backed by dedicated service to help improve patient outcomes.

* For complete indications and other important safety information for Gore commercial products referenced herein, refer to the applicable Instructions for Use (IFU).

MEDICAL PRODUCTS DIVISION

Gore Medical Products Division engineers devices that treat a range of cardiovascular and other health conditions. With more than 40 million medical devices implanted over the course of more than 40 years, Gore builds on its legacy of improving patient outcomes through research, education and quality initiatives. Product performance, ease of use and quality of service provide sustainable cost savings for physicians, hospitals and insurers. Gore is joined in service with clinicians and through this collaboration we are improving lives. www.goremedical.com

ABOUT GORE

W. L. Gore & Associates is a global materials science company dedicated to transforming industries and improving lives. Founded in 1958, Gore has built a reputation for solving complex technical challenges in the most demanding environments — from revolutionizing the outerwear industry with GORE-TEX® fabric to creating medical devices that improve and save lives to enabling new levels of performance in the aerospace, pharmaceutical and mobile electronics markets, among other industries. The company is also known for its strong, team-oriented culture and continued recognition from the Great Place to Work® Institute. Headquartered in Newark, Del., Gore employs approximately 9,500 Associates and generates annual revenues that exceed $3 billion. www.gore.com

Products listed may not be available in all markets. GORE®, VBX, and VIABAHN® are trademarks of W. L. Gore & Associates.

Contact information

Bliss Integrated Communication for Gore Medical
Claire LaCagnina, 212-840-8079
Claire@blissintegrated.com
or
Liz DeForest, 212-584-5477
Liz@blissintegrated.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Incognito Launches Digital Home Experience Solution25.4.2018 15:00Tiedote

Incognito Software Systems, a global provider of device and service management solutions for digital service providers, today introduced the Digital Home Experience Solution. The new offering enhances the existing Incognito Auto Configuration Server with improved digital channels, and analytics to address service quality challenges associated with complex, multi-device home WiFi networks. In production with a Tier 1 service provider, the solution is accelerating technical problem resolution, reducing operational costs with fewer truck rolls, while improving customer satisfaction. “Digital transformation in the home network is accelerating, as service providers look to eliminate friction points such as how to automate the resolution of service quality issues,” said Anil Rao, Principal Analyst, Analysys Mason. “It is in this context that Incognito’s new Digital Home Experience Solution is relevant. Communication service providers are investing in such solutions to boost customer satisfac

Boehringer Ingelheim R&D Pushes to Transcend Disease Boundaries25.4.2018 14:30Tiedote

Family-owned pharmaceutical company Boehringer Ingelheim today presented its latest pipeline updates at a Research & Development press conference entitled ‘Transcending Disease Boundaries’, at its global headquarters in Ingelheim, Germany. The company’s R&D strategy and current pipeline has the potential to deliver 15 new medicines for approval by 2025 (probability adjusted). With a high percentage of first-in-class and breakthrough potential drug candidates, Boehringer Ingelheim continues the successful implementation of its R&D strategy. Boehringer Ingelheim is committing more than €20 billion to Research & Development for human pharmaceuticals by 2025. In the past four years, the company received 14 regulatory approvals in several new indications, including four new molecular entities and four breakthrough designations by the US Food and Drug Administration. “The most ambitious goal for researchers is to achieve a medical breakthrough for patients from our over 80 clinical and pre-c

Corvidia Therapeutics Secures $60 Million in Series B Funding to Accelerate Clinical Work25.4.2018 14:00Tiedote

Corvidia Therapeutics Inc., a leading clinical stage biotechnology company, today announced the close of a $60 million USD Series B funding round. The financing will accelerate growth of Corvidia’s ongoing clinical programs, expand scientific and market access capabilities and explore new treatment areas. Venrock led the Series B financing and was joined by five additional new investors: Andera (formerly Edmond de Rothschild), Cormorant Asset Management, HBM Healthcare Investments, Fresenius Medical Care Ventures GmbH and Venrock Healthcare Capital Partners (VHCP). Series A investors Apple Tree Partners, MedImmune, the global biologics Research and Development arm of AstraZeneca, and Sofinnova Partners, the founding seed investor, also participated in this round. “We are extremely pleased to have reached such an important milestone in Corvidia’s advancement as a biotechnology company,” said Marc de Garidel, Chief Executive Officer of Corvidia Therapeutics Inc. “This funding is critical

LTI Congratulates American Modern Insurance Group, Inc. for Winning the Celent 2018 Model Insurer Award25.4.2018 13:30Tiedote

Larsen & Toubro Infotech Ltd. (NSE: LTI, BSE: 540005), a global technology consulting and digital solutions company, congratulates its client, American Modern Insurance Group, Inc. (American Modern) for winning Celent’s 2018 Model Insurer award. Celent is a global research and advisory firm for the financial services industry. American Modern, located in suburban Cincinnati, Ohio, provides specialty insurance products and services for the residential property and recreational markets. Celent’s annual Model Insurer Awards recognize the best practices of technology usage in areas critical to success in the insurance industry. American Modern is honored with a Celent 2018 Model Insurer award for operational excellence for its automation efforts that resulted in increased productivity and improved customer experience. A detailed case study of each winning initiative, including American Modern, is included in Celent’s annual Model Insurer report. Anil Vazirani, Chief Business Officer, Insur

Jam City Launches Harry Potter: Hogwarts Mystery On the App Store and Google Play25.4.2018 13:00Tiedote

Jam City, a Los Angeles based mobile games studio, announced today that the new mobile game Harry Potter: Hogwarts Mystery is available to download now on the App Store and Google Play. Developed by Jam City in partnership with Warner Bros. Interactive Entertainment, Harry Potter: Hogwarts Mystery is the first mobile game where players create their own character and experience life as a Hogwarts student. The game will launch under Warner Bros. Interactive Entertainment's Portkey Games, a label dedicated to creating new mobile and videogame experiences that place the player at the center of their own adventure, inspired by J.K. Rowling’s original stories. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180425005082/en/ Play Harry Potter: Hogwarts Mystery today! www.HarryPotterHogwartsMystery.com/ (Graphic: Business Wire) “There are so few moments where a mobile entertainment company has the chance to truly bring magic into the

GSMA Marks International Girls in ICT Day with Events around the World25.4.2018 11:00Tiedote

The GSMA will celebrate the annual ITU International Girls in ICT Day this week with a series of events across its global footprint aimed at encouraging and empowering young women to explore career opportunities in the science, technology, engineering and mathematics (STEM) areas and helping companies worldwide reap the benefits of greater female participation in the tech sector. The 2018 ITU International Girls in ICT Day will be held on Thursday 26 April and will be marked by events run by local GSMA offices in Atlanta, Barcelona, Brussels, Dubai, Hong Kong, London and Nairobi. “The GSMA is delighted to be supporting the ITU International Girls in ICT event for the fifth year running, inviting girls from around the world to learn about the rewarding careers possible within the mobile industry and the wider ICT sector,” said Mats Granryd, Director General, GSMA. “The future success of our industry rests on the ability to attract talented females and we hope to inspire a new generation

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme